Ligand Reports Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast at 8:30 a.m. Eastern Time Today SAN DIEGO, February 27, 2024 – Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today reported financial results for the three and twelve months ended December 31, 2023, and provided an operating forecast and business updates. Ligand management will host a conference call and webcast today beginning at 8:30 a.m. Eastern time to discuss this announcement and answer questions. “2023 ...